RNU6-1198P

Across TCGA pan-cancer cohorts, RNU6-1198P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RNU6-1198P data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher RNU6-1198P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1198P expression acts as an unfavorable survival marker, although some lineages such as STAD and LUAD show a favorable association.

TGCT, MESO, and UCEC are the cancer types where RNU6-1198P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	DFS	Tertile	II,III,IV	0.421	0.996	<.001	54	view →
MESO	OS	Tertile	All	0.052	0.528	.016	54	view →
UCEC	OS	Tertile	III,IV	0.234	0.613	.002	54	view →
STAD	OS	Median	All	0.768	0.607	.004	41	view →
LUAD	DFS	Tertile	II,III,IV	0.844	0.507	.014	36	view →
LIHC	OS	Tertile	All	0.518	0.784	.002	30	view →
HNSC	OS	Tertile	III,IV	0.267	0.683	.007	27	view →
THCA	DFS	Tertile	IV	0.300	0.833	.022	27	view →
ESCA	DFS	Quartile	All	0.334	0.542	.004	20	view →
THYM	OS	Tertile	III,IV	0.212	1.000	.014	18	view →
PAAD	OS	Tertile	II,III,IV	0.366	0.577	.019	9	view →
SKCM	DFS	Tertile	III,IV	0.123	0.654	.005	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RNU6-1198P–TGCT (DFS)

Open the TGCT breakdown →